• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Dick Cheney: Coronary heart disease treatment poster child

Dick Cheney: Coronary heart disease treatment poster child

March 31, 2011 By MassDevice staff

Dick Cheney

Dick Cheney

MASSDEVICE ON CALL — Should Dick Cheney get a new heart? Former vice president Dick Cheney may need a new heart to continue his 33-year battle with coronary heart disease treatment (he suffered the first of his four heart attacks when he was 37). Theheart.org asked several experts to weigh in on the matter, including Dr. Mandeep Mehra of the University of Maryland School of Medicine. Mehra said Cheney "would be a very deserving candidate for cardiac transplantation at this point," but Cheney’s advanced age of 70 is an issue. The relatively long life of the politically powerful cardiac patient is also raising concerns about inequities in healthcare.

RepubliCare = expensive. Republican alternatives to “Obamacare” would only cut less than .6 percent from federal healthcare spending, according to a Bloomberg study. “None of these proposals get to the heart of what the issue is, which is to really address cost,” says Ashish Kaura, a health-care analyst with Booz & Co. “They nibble around at the margins.”

Whistleblower James Allen’s eight year Guidant battle continues. Allen doesn’t believe the Dept. of Justice is doing enough in its lawsuit against Guidant Corp. over its alleged sale of faulty defibrillators, which it filed in January. The federal prosecutors charge that the company (now part of Boston Scientific Corp. (NYSE:BSX)) knowingly sold defective devices in 2002 and 2003, but Allen — who filed his own case against Guidant three years before the government — thinks the feds are missing the deapth and breadth of the company’s crimes, writes the Star Tribune.

CDC investigates Alabama over contaminated IVs. The Centers for Disease Control and Prevention and the Alabama Department of Public Health are investigating an outbreak of serratia marcescens bacteria among 19 patients who received intravenous treatment in six Yellowhammer State hospitals. The agencies have traced the problem to TPN, or total parenteral nutrition, produced by a single pharmacy, Birmingham-based Meds IV, according to a statement the ADPH, writes Law360.

FDA and EPA monitoring radiation in nation’s water supplies. The Environmental Protection Agency is taking steps to increase the level of nationwide monitoring of milk, precipitation, drinking water and other potential radiation exposure routes for radiation from Japan. EPA conducts radiological monitoring of milk under its RADNET program, while the Food & Drug Administration has jurisdiction over the safety, labeling and identity of milk and milk products in interstate commerce, the agency said.

Filed Under: News Well Tagged With: Boston Scientific, Guidant Corp.

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy